Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma.
作者信息
Sade-Feldman Moshe, Yizhak Keren, Bjorgaard Stacey L, Ray John P, de Boer Carl G, Jenkins Russell W, Lieb David J, Chen Jonathan H, Frederick Dennie T, Barzily-Rokni Michal, Freeman Samuel S, Reuben Alexandre, Hoover Paul J, Villani Alexandra-Chloé, Ivanova Elena, Portell Andrew, Lizotte Patrick H, Aref Amir R, Eliane Jean-Pierre, Hammond Marc R, Vitzthum Hans, Blackmon Shauna M, Li Bo, Gopalakrishnan Vancheswaran, Reddy Sangeetha M, Cooper Zachary A, Paweletz Cloud P, Barbie David A, Stemmer-Rachamimov Anat, Flaherty Keith T, Wargo Jennifer A, Boland Genevieve M, Sullivan Ryan J, Getz Gad, Hacohen Nir
出版信息
Cell. 2019 Jan 10;176(1-2):404. doi: 10.1016/j.cell.2018.12.034.
Abstract
摘要
相似文献
1
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma.定义与黑色素瘤中检查点免疫治疗反应相关的T细胞状态。
Cell. 2019 Jan 10;176(1-2):404. doi: 10.1016/j.cell.2018.12.034.
2
Intratumoral Tcf1PD-1CD8 T Cells with Stem-like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy.具有干性特征的肿瘤内 Tcf1PD-1CD8 T 细胞促进接种疫苗和检查点阻断免疫治疗后的肿瘤控制。
Immunity. 2019 Jan 15;50(1):195-211.e10. doi: 10.1016/j.immuni.2018.12.021. Epub 2019 Jan 8.
3
Metastatic melanoma and immunotherapy.转移性黑色素瘤与免疫疗法
Clin Immunol. 2016 Nov;172:105-110. doi: 10.1016/j.clim.2016.07.006. Epub 2016 Jul 16.
4
Timing and type of immune checkpoint therapy affect the early radiographic response of melanoma brain metastases to stereotactic radiosurgery.免疫检查点疗法的时机和类型会影响黑色素瘤脑转移瘤对立体定向放射外科治疗的早期影像学反应。
Cancer. 2016 Oct;122(19):3051-8. doi: 10.1002/cncr.30138. Epub 2016 Jun 10.
5
Checkpoint inhibitors in advanced melanoma: effect on the field of immunotherapy.晚期黑色素瘤中的检查点抑制剂：对免疫治疗领域的影响。
Expert Rev Anticancer Ther. 2017 Jul;17(7):647-655. doi: 10.1080/14737140.2017.1341315. Epub 2017 Jun 19.
6
Checkpoint Blockade for the Treatment of Advanced Melanoma.用于治疗晚期黑色素瘤的检查点阻断疗法。
Cancer Treat Res. 2016;167:231-50. doi: 10.1007/978-3-319-22539-5_9.
7
Immune Checkpoint Inhibitors: New Insights and Current Place in Cancer Therapy.免疫检查点抑制剂：癌症治疗的新见解及当前地位
Pharmacotherapy. 2015 Oct;35(10):963-76. doi: 10.1002/phar.1643.
8
Intralesional and systemic immunotherapy for metastatic melanoma.转移性黑色素瘤的瘤内和全身免疫治疗。
Expert Opin Biol Ther. 2016 Dec;16(12):1491-1499. doi: 10.1080/14712598.2016.1233961. Epub 2016 Sep 20.
9
Treatment of advanced melanoma with laser immunotherapy and ipilimumab.激光免疫疗法和伊匹单抗治疗晚期黑色素瘤
J Biophotonics. 2017 May;10(5):618-622. doi: 10.1002/jbio.201600271. Epub 2017 Apr 18.
10
The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma.下一代免疫检查点抑制剂：黑色素瘤中的PD-1/PD-L1阻断
Clin Ther. 2015 Apr 1;37(4):764-82. doi: 10.1016/j.clinthera.2015.02.018. Epub 2015 Mar 29.
引用本文的文献
1
Cell-Free DNA Bisulfite Sequencing Reveals Epithelial-Mesenchymal Transition Signatures for Breast Cancer.游离DNA亚硫酸氢盐测序揭示乳腺癌的上皮-间质转化特征
Int J Mol Sci. 2025 Sep 7;26(17):8723. doi: 10.3390/ijms26178723.
2
Exploring research trends in cancer immunotherapy via single-cell technologies: a scientometric perspective.从科学计量学角度探索通过单细胞技术进行癌症免疫治疗的研究趋势
Front Immunol. 2025 Aug 22;16:1640224. doi: 10.3389/fimmu.2025.1640224. eCollection 2025.
3
Reproducible single-cell annotation of programs underlying T cell subsets, activation states and functions.对T细胞亚群、激活状态和功能背后的程序进行可重复的单细胞注释。
Nat Methods. 2025 Sep 3. doi: 10.1038/s41592-025-02793-1.
4
Mature and migratory dendritic cells promote immune infiltration and response to anti-PD-1 checkpoint blockade in metastatic melanoma.成熟且具有迁移能力的树突状细胞促进转移性黑色素瘤中的免疫浸润及对抗程序性死亡蛋白1（PD-1）检查点阻断的反应。
Nat Commun. 2025 Sep 1;16(1):8151. doi: 10.1038/s41467-025-62878-5.
5
Lymph-node-derived stem-like but not tumor-tissue-resident CD8 T cells fuel anticancer immunity.淋巴结来源的干细胞样而非肿瘤组织驻留的CD8 T细胞促进抗癌免疫。
Nat Immunol. 2025 Aug;26(8):1367-1383. doi: 10.1038/s41590-025-02219-2. Epub 2025 Jul 29.
6
Research review of the mechanism and clinical application prospects of tertiary lymphoid structures in the immune micro-environment of gastrointestinal tumors.胃肠道肿瘤免疫微环境中三级淋巴结构的机制及临床应用前景研究综述
Oncol Res. 2025 Jun 26;33(7):1571-1580. doi: 10.32604/or.2025.058957. eCollection 2025.
7
Tumor site-directed A1R expression enhances CAR T cell function and improves efficacy against solid tumors.肿瘤部位定向的A1R表达增强了嵌合抗原受体（CAR）T细胞功能，并提高了对实体瘤的疗效。
Nat Commun. 2025 Jul 3;16(1):6123. doi: 10.1038/s41467-025-59021-9.
8
Application of single-cell and spatial omics in deciphering cellular hallmarks of cancer drug response and resistance.单细胞和空间组学在解读癌症药物反应和耐药性细胞特征中的应用。
J Hematol Oncol. 2025 Jul 2;18(1):70. doi: 10.1186/s13045-025-01722-1.
9
Overcoming resistance to immunotherapy by targeting CD38 in human tumor explants.通过靶向人类肿瘤外植体中的CD38克服免疫治疗耐药性。
Cell Rep Med. 2025 Jul 15;6(7):102210. doi: 10.1016/j.xcrm.2025.102210. Epub 2025 Jun 27.
10
CD8+ T Cell Subsets as Biomarkers for Predicting Checkpoint Therapy Outcomes in Cancer Immunotherapy.CD8+ T细胞亚群作为预测癌症免疫治疗中检查点治疗结果的生物标志物
Biomedicines. 2025 Apr 9;13(4):930. doi: 10.3390/biomedicines13040930.
Zotero 插件